Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Medtech lobby seeks broader device eligibility for CMS' proposed RAPID pathway

9 October 2026 · By · Wire by Fusion42

Published

9 October 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 9 October 2026 · Fusion42 review

The medtech industry group AdvaMed is lobbying to expand the eligibility criteria for CMS's proposed RAPID pathway to include more breakthrough devices and diagnostics, and is pushing for set timelines for national coverage determinations.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 8 Oct 2026 and 9 Oct 2026.

◆ ◆ The Wire takeaway

You can prepare to engage on broader device categories as CMS’ RAPID pathway opens new routes for faster market access and predictable reimbursement timelines.

◆ Coverage

2 sources · first reported 8 Oct 2026 · latest 9 Oct 2026

◆ Related on Wire

◆ Topics

Medtechmedtechregulatory-changecmshealth-policydevice-approval